These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29307015)

  • 1. Therapeutic approaches for induction of tolerance and immune quiescence in corneal allotransplantation.
    Tahvildari M; Amouzegar A; Foulsham W; Dana R
    Cell Mol Life Sci; 2018 May; 75(9):1509-1520. PubMed ID: 29307015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological correlation analysis of (lymph) angiogenesis and corneal graft rejection.
    Zheng Y; Lin H; Ling S
    Mol Vis; 2011; 17():1694-700. PubMed ID: 21738399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of donor corneal tissue with immunomodulatory cytokines: a novel strategy to promote graft survival in high-risk corneal transplantation.
    Tahvildari M; Emami-Naeini P; Omoto M; Mashaghi A; Chauhan SK; Dana R
    Sci Rep; 2017 Apr; 7(1):971. PubMed ID: 28428556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of resident accessory cells in corneal allograft rejection in the rabbit.
    Williams KA; Mann TS; Lewis M; Coster DJ
    Transplantation; 1986 Dec; 42(6):667-71. PubMed ID: 3538550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking neuropilin-2 enhances corneal allograft survival by selectively inhibiting lymphangiogenesis on vascularized beds.
    Tang XL; Sun JF; Wang XY; Du LL; Liu P
    Mol Vis; 2010 Nov; 16():2354-61. PubMed ID: 21139694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined blockade of VEGFR-3 and VLA-1 markedly promotes high-risk corneal transplant survival.
    Zhang H; Grimaldo S; Yuen D; Chen L
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6529-35. PubMed ID: 21715348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of Angiogenic Responses in Corneal Transplantation.
    Inomata T; Mashaghi A; Di Zazzo A; Lee SM; Chiang H; Dana R
    Cornea; 2017 Apr; 36(4):491-496. PubMed ID: 28060028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The taming of the shrew? The immunology of corneal transplantation.
    Pleyer U; Schlickeiser S
    Acta Ophthalmol; 2009 Aug; 87(5):488-97. PubMed ID: 19664109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corneal lymphangiogenesis: implications in immunity.
    Patel SP; Dana R
    Semin Ophthalmol; 2009; 24(3):135-8. PubMed ID: 19437348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Blockade of Vascular Endothelial Growth Factor C Effectively Inhibits Corneal Lymphangiogenesis and Promotes Allograft Survival.
    Yan H; Yuan J; Peng R; Wang T; Deng J; Li W; Ling S
    J Ocul Pharmacol Ther; 2015 Nov; 31(9):546-54. PubMed ID: 26172526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation.
    Bachmann BO; Bock F; Wiegand SJ; Maruyama K; Dana MR; Kruse FE; Luetjen-Drecoll E; Cursiefen C
    Arch Ophthalmol; 2008 Jan; 126(1):71-7. PubMed ID: 18195221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphangiogenesis occurring in transplanted corneas.
    Ling S; Qing X; Hu Y
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(2):241-4. PubMed ID: 16850758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation.
    Tahvildari M; Omoto M; Chen Y; Emami-Naeini P; Inomata T; Dohlman TH; Kaye AE; Chauhan SK; Dana R
    Transplantation; 2016 Mar; 100(3):525-32. PubMed ID: 26881788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune privilege of corneal allografts.
    Niederkorn JY; Larkin DF
    Ocul Immunol Inflamm; 2010 Jun; 18(3):162-71. PubMed ID: 20482389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crucial role of corneal lymphangiogenesis for allograft rejection in alkali-burned cornea bed.
    Ling S; Qi C; Li W; Xu J; Kuang W
    Clin Exp Ophthalmol; 2009 Dec; 37(9):874-83. PubMed ID: 20092597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome.
    Fuentes-Julián S; Arnalich-Montiel F; Jaumandreu L; Leal M; Casado A; García-Tuñon I; Hernández-Jiménez E; López-Collazo E; De Miguel MP
    PLoS One; 2015; 10(3):e0117945. PubMed ID: 25730319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cell modulation of cytokine and cellular networks in corneal graft rejection.
    Tahvildari M; Inomata T; Amouzegar A; Dana R
    Curr Ophthalmol Rep; 2018 Dec; 6(4):266-274. PubMed ID: 31807370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloimmunity and Tolerance in Corneal Transplantation.
    Amouzegar A; Chauhan SK; Dana R
    J Immunol; 2016 May; 196(10):3983-91. PubMed ID: 27183635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunobiology of corneal transplantation.
    Williams KA; Coster DJ
    Transplantation; 2007 Oct; 84(7):806-13. PubMed ID: 17984831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology.
    Cursiefen C; Chen L; Dana MR; Streilein JW
    Cornea; 2003 Apr; 22(3):273-81. PubMed ID: 12658100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.